I vincitori delle principali edizioni del Prix Galien negli ultimi anni
| RHUMATOLOGY | 2011 | DENOSUMAB (Prolia) | AMGEN | BELGIUM |
| ONCOLOGY | 2011 | Role of chimokines and their use as markers | Pr Struyf (Institut Rega, universit royale de Louvain) | BELGIUM |
| CARDIOLOGY | 2011 | DABIGATRAN (Pradaxa) | BOEHRINGER INGELHEIM | CANADA |
| HEMATOLOGY | 2011 | Human Fibrinogen (Clottafact) | LFB | FRANCE |
| VACCINOTHERAPY | 2011 | IXIARO, Japanese encephalitis vaccine | NOVARTIS. VACCINS. | FRANCE |
| RHUMATOLOGY | 2011 | TOCILIZUMAB (Roactemra) | ROCHE | FRANCE |
| RHUMATOLOGY | 2011 | DENOSUMAB (Prolia) | AMGEN/GSK | GERMANY |
| UROLOGY | 2011 | Role of ciliary activity on mTOR inhibition | Pr Khn | GERMANY |
| HEMATOLOGY | 2011 | ROMIPLOSTIM (nPlate) | AMGEN | GERMANY |
| BIOCHEMISTRY | 2011 | Molecular Design and Chemical Synthesis | Dr de Esch | NETHERLANDS |
| HEMATOLOGY | 2011 | OFATUMUMAB (Arzerra) | GSK | NETHERLANDS |
| PUBLIC HEALTH | 2011 | Phamaco-epidemiology work | Dr Ramon Laporte Rosello | SPAIN |
| HEMATOLOGY | 2011 | PLERIXAFOR (Mozobil) | GENZYME | SPAIN |
| CARDIOLOGY | 2011 | IVABRADINE (Procoralan) | SERVIER | SWITZERLAND |
| RHUMATOLOGY | 2011 | DENOSUMAB (Prolia) | AMGEN | USA |
| VACCINOTHERAPY | 2011 | PREVENAR 13 pneumococcal polysaccharide | PFIZER | USA |
| VACCINOTHERAPY | 2011 | ROTATEQ, rotavirus vaccine | SANOFI-PASTEUR-M.S.D. | USA |
| NEUROLOGY | 2011 | USTEKINUMAB (Stelara) | JANSSEN BIOTECH | USA |
| INFECTIOLOGY | 2012 | BOCEPREVIR (Victrelis) | MERCK MSD | BELGIUM |
| CARDIOLOGY | 2012 | Importance of von Willebrand Factor in the cerebrovascular accident | Pr de Meyer (KULeuven | BELGIUM |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | BELGIUM |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | CANADA |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | CANADA |
| INFECTIOLOGY | 2012 | Works on antibiotic resistance | Dr Hankok | CANADA |
| INFECTIOLOGY | 2012 | BOCEPREVIR (Victrelis) | MERCK MSD | FRANCE |
| IMMUNOLOGY | 2012 | Development of antiviral vectors | Pr Hacein-bey Abina | FRANCE |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | FRANCE |
| BIOCHEMISTRY | 2012 | Works on ion channels | Pr Lazdunski | FRANCE |
| NEUROLOGY | 2012 | FINGOLIMOD (Gilenya) | NOVARTIS | GERMANY |
| ONCOLOGY | 2012 | VEMURAFENIB (Zelboraf) | ROCHE | GERMANY |
| ONCOLOGY | 2012 | Works on Metastatic Cancer | Dr Worzfeld(Institut Max-Planck, Bad-Nauheim) | GERMANY |
| NEUROLOGY | 2012 | USTEKINUMAB (Stelara) | JANSSEN BIOTECH | INTERNATIONAL |
| NEUROPSYCHIATRY | 2012 | AGOMELATINE (Valdoxan) | SERVIER | ITALY |
| NEUROLOGY | 2012 | FINGOLIMOD (Gilenya) | NOVARTIS | ITALY |
| ONCOLOGY | 2012 | IFOM Foundation, IFRC Institute for Molecular Oncology | SOFIA FRANCIA | ITALY |
| ONCOLOGY | 2012 | CATUMAXOMAB (Removab) | FRESENIUS BIOTECH | NETHERLANDS |
| CARDIOLOGY | 2012 | Regulation of genetic mechanisms in heart failure | Pr dr de Windt, MUNC | NETHERLANDS |
| INDUSTRIAL RESEARCH | 2012 | Computerized clinical studies of pulmonary and cardiological diseases | Institut PAN | POLAND |
| CARDIOLOGY | 2012 | DABIGATRAN (Pradaxa) | BOEHRINGER INGELHEIM | POLAND |
| MEDICAL TECHNOLOGY | 2012 | Development of an electronic chip | Institut STUCHU | POLAND |
| MEDICAL TECHNOLOGY | 2012 | Development of computer-based clinical studies for pulmonary and cardiac diseases | Institut PAN | POLAND |
| VACCINOTHERAPY | 2012 | PREVENAR 13, pneumococcal polysaccharide | PFIZER | POLAND |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | POLAND |
| RHUMATOLOGY | 2012 | DENOSUMAB (Prolia) | AMGEN/GSK | SWITZERLAND |
| INFECTIOLOGY | 2012 | BOCEPREVIR (Victrelis) | MERCK MSD | UNITED KINGDOM |
| ONCOLOGY | 2012 | INN-MIFAMURTIDE (Mepact) | TAKEDA | UNITED KINGDOM |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | UNITED KINGDOM |
| INFECTIOLOGY | 2012 | BOCEPREVIR (Victrelis) | MERCK MSD | USA |
| ONCOLOGY | 2012 | YERVOY (ipilimumab) | B.M.S. | USA |
| MEDICAL TECHNOLOGY | 2012 | Melody Transcatheter Pulmonary valve (RPV) Therapy (Metrotonic) | MEDTRONIC | USA |
| MEDICAL TECHNOLOGY | 2012 | Sapien3 Transcatheter Heart valve | EDWARDS LIFESCIENCES | USA |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | USA |
| ONCOLOGY | 2013 | CRIZOTINIB (Xalkori) | PFIZER | BELGIUM |
| ONCOLOGY | 2013 | Targets and tools on lymphoid tumors | Pr Geert Bultync (KULeuven) | BELGIUM |
| ONCOLOGY | 2013 | IPILIMUMAB (Yervoy) | B.M.S. | CANADA |
| VACCINOTHERAPY | 2013 | BEXSERO | NOVARTIS VACCINS | FRANCE |
| PNEUMOLOGY | 2013 | IVACAFTOR (Kalydeco) | VERTEX PHARMACEUTICALS | FRANCE |
| INFECTIOLOGY | 2013 | Modeling of antiviral hepatitis C therapy | Pr Baumert | FRANCE |
| PNEUMOLOGY | 2013 | IVACAFTOR (Kalydeco) | VERTEX PHARMACEUTICALS | GERMANY |
| ONCOLOGY | 2013 | PERTUZUMAB (Perjeta) | ROCHE | GERMANY |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2013 | RIFAXIMIN (Xifaxan) | NORGINE GmBH | GERMANY |
| ONCOLOGY | 2013 | VEMURAFENIB (Zelboraf) | ROCHE | GERMANY |
| NEPHROLOGY | 2013 | Works on the ACE therapeutic inhibitor on Alport syndrome | Pr Dr Gross | GERMANY |
| MEDICAL TECHNOLOGY | 2013 | Cobas HPV Test (detection of oncogenic papillomaviruses) | ROCHE DIAGNOSTICS | GREECE |
| NEUROLOGY | 2013 | FINGOLIMOD (Gilenya) | NOVARTIS | GREECE |
| HEMATOLOGY | 2013 | PLERIXAFOR (Mozobil) | SANOFI | GREECE |
| HEMATOLOGY | 2013 | ROMIPLOSTIM (nPlate) | AMGEN | GREECE |
| RHUMATOLOGY | 2013 | TOCILIZUMAB (Roactemra) | ROCHE | GREECE |
| PNEUMOLOGY | 2013 | IVACAFTOR (Kalydeco) | VERTEX PHARMACEUTICALS | INTERNATIONAL |
| BIOCHEMISTRY | 2013 | Biomimetic support systems for biotherapeutics | Pr Mastrobattista, université d’Ultrech | NETHERLANDS |
| PNEUMOLOGY | 2013 | IVACAFTOR (Kalydeco) | VERTEX PHARMACEUTICALS | NETHERLANDS |
| ONCOLOGY | 2013 | PEMETREXED (Alimta) | ELI LILLY | NETHERLANDS |
| HEMATOLOGY | 2013 | BRENTUXIMAB (Adcetris) | PFIZER | RUSSIA |
| OPHTHALMOLOGY | 2013 | RANIBIZUMAB (Lucentis) | NOVARTIS | RUSSIA |
| PHARMACOLOGY | 2013 | Works on nanomodular transmitters | Pr Sobolev, Pr Rosenkranz, Pr Lunin | RUSSIA |
| ONCOLOGY | 2013 | VEMURAFENIB (Zelboraf) | ROCHE | SWITZERLAND |
| ONCOLOGY | 2013 | VEMURAFENIB (Zelboraf) | ROCHE | USA |
| ONCOLOGY | 2014 | TRASTUZUMAB EMTANSIN T-DM1 (Kadcyla) | ROCHE | BELGIUM |
| PNEUMOLOGY | 2014 | PIRFERIDONE (Esbriet) | ROCHE-INTERMUNDE | CANADA |
| INFECTIOLOGY | 2014 | Work in microbiology, pharmacology, vaccine development | Dr Finlay | CANADA |
| INFECTIOLOGY | 2014 | Work on HIV | Dr Plummer | CANADA |
| RHUMATOLOGY | 2014 | CANAKITUMAB (Ilaris) | NOVARTIS | FRANCE |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2014 | ORPHACOL (cholic acid) | CTRS | FRANCE |
| CARDIOLOGY | 2014 | Identification of therapeutic targets and new compounds in hypertension and heart failure | Dr Catherine Llorens-Cortes, Collge de France | FRANCE |
| DERMATOLOGY | 2014 | PROPANOLOL (Hemangiol) | PIERRE FABRE DERMATOLOGIE | FRANCE |
| PNEUMOLOGY | 2014 | BEDAQUILINE (Sirturo) | JANSSEN | GERMANY |
| NEUROLOGY | 2014 | DIMETHYLFUMARAT (Tecfidera) | BIOGEN IDEC | GERMANY |
| NEPHROLOGY | 2014 | Role of the immune system in kidney disease | Dr. Sker et Pr Zippel, Universit Jena Leibniz-Institut | GERMANY |
| INFECTIOLOGY | 2014 | SOFOSBUVIR (Solvadi) | GILEAD SCIENCES | GERMANY |
| VACCINOTHERAPY | 2014 | BEXSERO | NOVARTIS | ITALY |
| ONCOLOGY | 2014 | Works on stem cell transplantation in dystrophic muscles. | Dr Giannotta, Istituto FIRC di Oncologia Molecolare (IFOM), Milano | ITALY |
| ONCOLOGY | 2014 | Identification of targets and markers in brain tumors | Dr. Tom Wrdinger, Pr Ren Bernards, Nederlands Kanker Instituut – Antoni van Leeuwenhoek (NKI-AVL) | NETHERLANDS |
| VACCINOTHERAPY | 2014 | BEXSERO | NOVARTIS | POLAND |
| HEMATOLOGY | 2014 | BRENTUXIMAB (Adcetris) | TAKEDA | POLAND |
| INFECTIOLOGY | 2014 | SOFOSBUWIR (Solvadi) | GILEAD SCIENCES | POLAND |
| MEDICAL TECHNOLOGY | 2014 | Cobas HPV Test (detection of oncogenic papillomaviruses) | ROCHE DIAGNOSTICS | RUSSIA |
| MEDICAL TECHNOLOGY | 2014 | Diaskintest | GENERIUM | RUSSIA |
| VACCINOTHERAPY | 2014 | PREVENAR 13, pneumococcal polysaccharide | PFIZER | RUSSIA |
| CARDIOLOGY | 2014 | TICAGRETOL (Brilinta) | ASTRA-ZENECA | RUSSIA |
| NEUROLOGY | 2014 | FINGOLIMOD (Gilenya) | NOVARTIS | SWITZERLAND |
| VACCINOTHERAPY | 2014 | BEXSERO | NOVARTIS | UNITED KINGDOM |
| PNEUMOLOGY | 2014 | IVACAFTOR (Kalydeco) | VERTEX PHARMACEUTICALS | UNITED KINGDOM |
| BIOTECHNOLOGY | 2014 | Cord Blood (Hemacord) | New York Blood Center Howard Milstein | USA |
| INFECTIOLOGY | 2014 | PIRFENIDONE (Esbriet) | INTERMUNDE | USA |
| MEDICAL TECHNOLOGY | 2014 | Provue Retriever (Trevo) | STRYKER | USA |
| INFECTIOLOGY | 2014 | SOFOSBUVIR (Solvadi) | GILEAD SCIENCES | USA |
| MEDICAL TECHNOLOGY | 2014 | Subcutaneous implantation defibrillator (S-ICD system) | Boston Scientific | USA |
| ONCOLOGY | 2015 | Works on bioavailable oral inhibitor of fibroblast activation protein (FAP) | Pr Van der Veken (Universiteit Antwerpen) | BELGIUM |
| ONCOLOGY | 2015 | AFATINIB (Giotrif) | BOEHRINGER-INGELHEIM | CANADA |
| HEMATOLOGY | 2015 | Works on possible treatments for heparin-induced thrombocytopenia. | Drs Kelton et Warkentin (universit McMaster) | CANADA |
| ONCOLOGY | 2015 | IBRUTINIB (Imbruvica) | Janssen Biotech, Inc. & Pharmacyclics LLC, and AbbVie Company | FRANCE |
| ADDICTOLOGY | 2015 | NALMEFENE (Selingro) | LUNDBECK | GERMANY |
| ONCOLOGY | 2015 | RADIUM 223 DICHLORID (Xofigo) | BAYER HEALTHCARE | GERMANY |
| PHARMACOLOGY | 2015 | Works on the study of capsaicin receptors TRPV1 | Pr Siemens | GERMANY |
| RHUMATOLOGY | 2015 | All work in rheumatology | Dr Kollias, centre de recherche Alexander Flemming | GREECE |
| RHUMATOLOGY | 2015 | DENOSUMAB (Prolia) | AMGEN | GREECE |
| CARDIOLOGY | 2015 | MACITENTAN (Erivedge) | ACTELION PHARMACEUTICALS HELLAS | GREECE |
| MEDICAL TECHNOLOGY | 2015 | MIYABI medical imaging diagnostic | Siemens Healthcare Hellas | GREECE |
| INFECTIOLOGY | 2015 | SOFOSBUVIR (Solvadi) | GILEAD HELLAS | GREECE |
| ONCOLOGY | 2015 | VISMODEGIB (Erivedge) | ROCHE HELLAS | GREECE |
| PNEUMOLOGY | 2015 | BEDAQUILINE (Sirturo) | JANSSEN | NETHERLANDS |
| PHARMACOLOGY | 2015 | Works on the personalization of dosages according to the populations in reaction to drugs pharmacokinetics and pharmacodynamics. | Dr. A. Huitema | NETHERLANDS |
| VACCINOTHERAPY | 2015 | 6-in-1 infant vaccine | SANOFI-PASTEUR | POLAND |
| MEDICAL TECHNOLOGY | 2015 | CyberOko – diagnosis and treatment of comatose states | Pr Andrzej Czyzewski (université de Gdańsk) | POLAND |
| ONCOLOGY | 2015 | NIVOLUMAB (Opdivo) | B.M.S. | POLAND |
| DERMATOLOGY | 2015 | KEYTRUDA (pembrolizumab) | MERCK | POLAND |
| ONCOLOGY | 2015 | PERTUZUMAB (Perjeta) | ROCHE | POLAND |
| ONCOLOGY | 2015 | Treatment of caustic oesophageal stenosis by a removable stent | Pr Marek Woynarowski (Institut Memorial Health The Children) | POLAND |
| DERMATOLOGY | 2015 | Works on Supporting Polymer | CENTRE DES MATERIAUX DE POLYMERE ET DE CARBONE-ACADEMIE POLONAISE DES SCIENCES-PAN | POLAND |
| HEMATOLOGY | 2015 | BRENTUXIMAB (Adcetris) | TAKEDA | SWITZERLAND |
| HEMATOLOGY | 2015 | IBRUTINIB (Imbruvica) | JANSSEN | USA |
| ONCOLOGY | 2015 | NIVOLUMAB (Opdivo) | B.M.S. | USA |
| DERMATOLOGY | 2015 | PEMBROLIZUMAB (Keytruda) | MERCK | USA |
| MEDICAL TECHNOLOGY | 2015 | T2Candida Pane | T2 Biosystems | USA |
| ONCOLOGY | 2016 | NIVOLUMAB (Opdivo) | B.M.S. | BELGIUM |
| DERMATOLOGY | 2016 | PEMBROLIZUMAB (Keytruda) | MERCK | BELGIUM |
| MEDICAL TECHNOLOGY | 2016 | S-ICD EMBLEM | Boston Scientific | BELGIUM |
| PHARMACOLOGY | 2016 | Works the pharmacological targets for brain diseases and cardiovascular diseases | Dr De Bock, Dr Decrock and Dr Wang | BELGIUM |
| GASTROENTEROLOGY | 2016 | ENTYVIO (Vedolizumab) | TAKEDA | CANADA |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2016 | HARVONI (Sofosbuvir/Ledipasvir) | GILEAD SCIENCES | CANADA |
| IMMUNOLOGY | 2016 | Work on drastic reduction of transplantation failure rates | Dr. Philip F Halloran | CANADA |
| INFECTIOLOGY | 2016 | AUTOTEST VIH | AAZ | FRANCE |
| NEUROMUSCULAR DISEASES | 2016 | ATALUREN (Translarna ™) | PTC Therapeutics | FRANCE |
| ENDOCRINOLOGY | 2016 | KANUMA (sebelipase alfa) | ALEXION | GERMANY |
| PNEUMOLOGY | 2016 | SIRTURO (Bedaquiline) | JANSSEN | INTERNATIONAL |
| DERMATOLOGY | 2016 | KEYTRUDA (Pembrolizumab) | MERCK | INTERNATIONAL |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2016 | ORPHACOL (cholic acid) | CTRS | INTERNATIONAL |
| OPHTHALMOLOGY | 2016 | Ex vivo expanded autologous human corneal epithelial cells | CHIESI | NETHERLANDS |
| ENDOCRINOLOGY | 2016 | Works on specialized medicine for patients with diabetes or kidney disease | Dr Hiddo Lambers Heerspink (universit de Groningen) | NETHERLANDS |
| CARDIOLOGY | 2016 | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM | POLAND |
| ONCOLOGY | 2016 | IMBRUVICA (Ibrutinib) | JANSSEN | POLAND |
| INFECTIOLOGY | 2016 | 9-valent vaccine against human papillomavirus (recombined, adsorbed) | MSD | POLAND |
| ONCOLOGY | 2016 | BLINATUMOMAB | AMGEN | POLAND |
| CARDIOLOGY | 2016 | Servier for the Heart preventive educational campaign | Servier Polska | POLAND |
| OSTEOLOGY | 2016 | Work on a new generation, bone-replacement implanting biomaterial for regenerative medicine (“artificial bone”) | Prof. Grażyna Ginalska | POLAND |
| ONCOLOGY | 2016 | IMBRUVICA (Ibrutinib) | JANSSEN | RUSSIA |
| ONCOLOGY | 2016 | BLINATUMOBAB | AMGEN | RUSSIA |
| ONCOLOGY | 2016 | YERVOY (Ipilimumab) | BRISTOL-MYERS SQUIBB | RUSSIA |
| CARDIOLOGY | 2016 | ABSORB Bioresorbable Vascular Scaffold | ABBOTT | RUSSIA |
| INFECTIOLOGY | 2016 | Work on the development of a new generation of antivirals of the family of azoloazines | Valery Charushin, Oleg Chupakhin and Vladimir Rusinov | RUSSIA |
| OBSTETRICS/GYNECOLOGY | 2016 | “Femoflor”&”ImmunoQuantex” for differential and complex diagnosis of different clinical condition connected with dysbiotic disorders and inflammatory conditions of the lower reproductive tract of women | DNA-Technology and Federal State Budget Institution “Research Center for Obstetrics, Gynecology and Perinatology” Ministry of Healthcare of the Russian Federation | RUSSIA |
| DERMATOLOGY | 2016 | SECUKINUMAB (Cosentyx) | NOVARTIS PHARMA | SWITZERLAND |
| OPHTHALMOLOGY | 2016 | Ex vivo expanded autologous human corneal epithelial cells | CHIESI | UNITED KINGDOM |
| CARDIOLOGY | 2016 | SACUBITRIL: VALSARTAN (Entresto) | NOVARTIS | UNITED KINGDOM |
| DERMATOLOGY | 2016 | COSENTYX | NOVARTIS | USA |
| ONCOLOGY | 2016 | IBRANCE (palbociclib) | PFIZER | USA |
| MEDICAL TECHNOLOGY | 2016 | COLOGUARD | EXACT SCIENCES | USA |
| ONCOLOGY | 2016 | GLEEVEC (imatinib) | NOVARTIS (Discovery of the Decade) | USA |
| ONCOLOGY | 2016 | YERVOY (Ipilimumab) | BRISTOL-MYERS SQUIBB (Discovery of the Decade) | USA |
| MEDICAL TECHNOLOGY | 2016 | SAPIEN3 Transcatheter Heart valve | EDWARDS LIFESCIENCES (Discovery of the Decade) | USA |
| ONCOLOGY | 2017 | TAGRISSO (Osimertinib) | AstraZeneca | GREECE |
| ONCOLOGY | 2017 | OPDIVO (Nivolumab) | Bristol Myers Squibb | GREECE |
| DERMATOLOGY | 2017 | KEYTRUDA (Pembrolizumab) | Merck Sharp & Dohme (MSD) | GREECE |
| ONCOLOGY | 2017 | OFEV (Nintedanib) | Boehringer Ingelheim | GREECE |
| MEDICAL TECHNOLOGY | 2017 | Cobas® EGFR Mutation Test v2 | Roche Diagnostics (Hellas) | GREECE |
| IMMUNOLOGY | 2017 | Strimvelis | GSK | NETHERLANDS |
| CARDIOLOGY | 2017 | Repatha (Evolocumab) | Amgen | SWITZERLAND |
| ONCOLOGY | 2017 | Venclexta (venetoclax) tablets | AbbVie | GERMANY |
| CARDIOLOGY | 2017 | Entresto (Sacubitril / Valsartan) | Novartis | GERMANY |
| PULONOLOGY | 2017 | Cinqaero (Reslizumab) | TEVA | GERMANY |
| SPINAL MUSCULAR ATROPHY (SMA) | 2017 | Spinraza | Biogen & Ionis Pharmaceuticals | USA |
| ONCOLOGY | 2017 | Venclexta (venetoclax) tablets | AbbVie & Genentech (a Member of the Roche Group) | USA |
| NEUROLOGY | 2017 | Exablate Neuro | INSIGHTEC | USA |
| SPINAL MUSCULAR ATROPHY (SMA) | 2018 | Spinraza | Biogen | United Kingdom |
| MEDICAL DEVICE | 2018 | Solitaire Platinum | Medtronic | United Kingdom |
| RARE DISEASES | 2018 | Galafold | Amicus | United Kingdom |
| TECHNOLOGY | 2018 | WATCHMAN | Boston Scientific | USA |
| HEMATOLOGY/ONCOLOGY | 2018 | IDHIFA | Celgene-Agios | USA |
| ONCOLOGY | 2018 | Kymriah | Novartis | USA |
| ONCOLOGY | 2018 | Yescarta | Kite, a Gilead Company | USA |
| SPINAL MUSCULAR ATROPHY (SMA) | 2018 | Spinraza | Biogen | Netherland |
| MEDICAL DEVICE | 2018 | FreeStyle Libre | Abbott | Netherland |
| SPINAL MUSCULAR ATROPHY (SMA) | 2018 | Spinraza | Biogen | France |
| HEMOPHILIA | 2018 | Hemlibra® (émicizumab) | Roche France et Chugai Pharma France | France |
| MEDICAL DEVICE | 2018 | UrgoStart | Urgo Medical | France |
| INFECTIOUS DISEASES | 2018 | Zinplava® (bezlotoxumab) | MSD Sharp & Dohme | Germany |
| HEMOPHILIA | 2018 | Hemlibra® (émicizumab) | Roche France et Chugai Pharma France | Germany |
| SPINAL MUSCULAR ATROPHY (SMA) | 2018 | Spinraza | Biogen | Germany |
| OPHTHALMOLOGY | 2018 | Holoclar® | Chiesi | Germany |
| Best Medical Technology | 2018 | Autotest VIH | AAZ-LMB | International |
| Best Pharmaceutical Product | 2018 | Jardiance | Boehringer Ingelheim | International |
| Best Biotechnology Product | 2018 | Spinraza | Biogen | International |
| BEST MEDICAL TECHNOLOGY PRODUCT | 2019 | FOUNDATIONONE CDX – FOUNDATIONONE LIQUID | ROCHE | GREECE |
| BEST MEDICAL TECHNOLOGY PRODUCT | 2019 | POMPOTIKO XEIPOYPGIKO SYSTHMA DA VINCI XILOPOPMA 4TH GENIA | SOFMEDICA | GREECE |
| PHARMACEUTICAL PRODUCT | 2019 | TAGRISSO (Osimertinib) | ASTRAZENECA (Discovery of the Last Five Years) | GREECE |
| BIOTECHNOLOGY PRODUCT | 2019 | KEYTRUDA (Pembrolizumab) | MSD (Discovery of the Last Five Years) | GREECE |
| PRODUCT FOR RARE DISEASE | 2019 | OFEV (Nintedanib) | BOEHRINGER INGELHEIM (Discovery of the Last Five Years) | GREECE |
| MEDICAL TECHNOLOGY PRODUCT | 2019 | NEXARIS ANGIO-CT-MR | SIEMENS HEALTHINEERS(Discovery of the Last Five Years) | GREECE |
| BEST PHARMACEUTICAL PRODUCT | 2019 | LYMPARZA (Olaparib) | MSD | GREECE |
| BEST PHARMACEUTICAL PRODUCT | 2019 | LYMPARZA (Olaparib) | ASTRAZENECA | GREECE |
| BEST PHARMACEUTICAL PRODUCT | 2019 | ZAVICEFTA (Ceftazidime-avibactam) | PFIZER HOSPITAL | GREECE |
| BEST BIOTECHNOLOGY PRODUCT | 2019 | KYMRIAH(Tisagenlecleucel) | NOVARTIS | GREECE |
| BEST PRODUCT FOR RARE DISEASE | 2019 | ADCETRIS (Brentuximab Vedotin) | TAKEDA ONCOLOGY | GREECE |
| Prize medicin | 2019 | Kymriah® (tisagenlecleucel) | Novartis | BELGIUM / LUXEMBURG |
| Prize medicin | 2019 | Yescarta® (axicabtagene ciloleucel) | Gilead | BELGIUM / LUXEMBURG |
| Prize Farmacology | 2019 | Study: Tumor cell metabolism: new therapeutic opportunities from microenvironmental acidosis | Dr Cyril Corbet – UCLouvain | BELGIUM / LUXEMBURG |
| Medical Devices Prize Laureate | 2019 | Magseed/Magtrace | Sysmex | BELGIUM / LUXEMBURG |
| Spinal Muscular Atrophy (SMA) | 2019 | Spinraza (nusinersen) | Biogen | SWITZERLAND |
| 2019 | RYDAPT (midostaurin, formerly PKC412) | Novartis | SWITZERLAND | |
| 2019 | Jardiance | Boehringer-Ingelheim | SWITZERLAND | |
| Vaccinology | 2019 | SHINGRIX | GSK | CANADA |
| Winner Medicines Orphan Drugs | 2019 | YESCARTA | GILEAD / KITE | GERMANY |
| Winner Medicines Orphan Drugs | 2019 | KYMRIAH | NOVARTIS | GERMANY |
| Winner Medicines Specialist Care | 2019 | REAGILA | RECORDATI PHARMA | GERMANY |
| Winner Medicines Primary Care | 2019 | SHINGRIX | GSK | GERMANY |
| Research Achievement in Clinical or Experimental Pharmacology | 2019 | Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in in fully immunocompetent allogeneic recipients | Sonja Schrepfer, MD, PhD, Professor of Surgery, University Heart Center Hamburg Transplant and Stem Cell Immunobiology Lab | GERMANY |
| Vaccinology | 2019 | SHINGRIX | GSK | USA |
| Ophthalmology | 2019 | LUXTURNA™ (voretigene neparvovec-rzyl) | Spark Therapeutics | USA |
| Medical Technology | 2019 | FreeStyle® Libre 14 Day Flash Glucose Monitoring System | Abbott | USA |
| Winner Medicines Orphan Drugs | 2019 | Yescarta | Gilead( Kite) | FRANCE |
| Winner Medicines Orphan Drugs | 2019 | Dupixent | Sanofi | FRANCE |
| Winner Medicines Orphan Drugs | 2019 | Kymriah and Luxturna | Novartis | FRANCE |
| MEDICAL TECHNOLOGY | 2019 | EarlySense | Devices4Care | NETHERLANDS |
| RESEARCH | 2019 | Prof. Dr. Jeffrey Beekman, Professor of Cellular Disease Models, Pediatric Pulmonology | UMC Utrecht | NETHERLANDS |
| RARE DISEASE | 2019 | Onpattro® (patisiran) | Alnylam Pharmaceuticals | NETHERLANDS |
| Best Pharmaceutical Agent | 2020 | Pretomanid | TB Alliance | USA |
| Best Biotechnology Product | 2020 | TEGSEDI® | Akcea Therapeutics and Ionis Pharmaceuticals | USA |
| RARE DISEASE | 2020 | ONPATTRO® (patisiran) | Alnylam Pharmaceuticals | USA |
| Best Biotechnology Product | 2020 | Pfizer | VYNDAQEL® (tafamidis meglumine) | USA |
| Best Medical Technology | 2020 | Abbott’s MitraClip™ Transcatheter Mitral Valve Repair System | Abbott | USA |
| Best Digital Health Product | 2020 | Somryst | Pear Therapeutics | USA |
| Category Primary & Speciality | 2020 | Aimovig® | Novartis | SWITZERLAND |
| Category Cancer | 2020 | Venclyxto® | Abbvie | SWITZERLAND |
| Category Orphan Diseases | 2020 | Revestive® | Takeda | SWITZERLAND |
| Category HEMATOLOGY | 2020 | Cablivi | Sanofi Genzyme | GERMANY |
| Category ENDOCRYNOLOGY | 2020 | Rybelsus | Novo Nordisk | GERMANY |
| Category HEMATOLOGY | 2020 | Ondexxya | Portola | GERMANY |
| Infectiology | 2021 | Saytu Covid-19 Antigen | Diatropix | Africa |
| Neurology | 2021 | Fexinidazole | Drugs for Neglected Diseases initiative (DNDi) | Africa |
| Oncology Hematology | 2021 | Wikiboop | Roche | France |
| Cardiology | 2021 | Vyndaqel | Pfizer | France |
| Oncology Hematology | 2021 | Venclyxto | AbbVie | France |
| Cardiology | 2021 | Titan Optimax | Hexacath | France |
| Infectiology | 2021 | Spikevax | Moderna | France |
| Infectiology | 2021 | Medication Shield | Synapse Medicine | France |
| Dermatology | 2021 | Healico | Urgo Medical | France |
| Vaccinology | 2021 | Gardasil 9 | Merck &Cie | France |
| Vaccinology | 2021 | Comirnaty | Pfizer | France |
| Hepatology Gastroenterology | 2021 | Alofisel | Takeda | France |
| Neurology | 2021 | Zolgensma | Novartis | Germany |
| Hepatology Gastroenterology | 2021 | Givlaari | Alnylam Pharmaceuticals | Germany |
| Vaccinology | 2021 | Comirnaty | Pfizer / BioNTech | Germany |
| Neurology | 2021 | Zolgensma | Novartis | Greece |
| Endocrinology | 2021 | Ozempic | NovoNordisk | Greece |
| Pneumology | 2021 | Kalydeco | Vertex | Greece |
| Oncology Hematology | 2021 | Imfinzi | AstraZeneca | Greece |
| Cardiology | 2021 | Carto Prime | Biosense Webster | Greece |
| Prix Galien MedTech Innovation Award 2021 | 2021 | VRelax-glasses including software | VRelax | Netherlands |
| Prix Galien Pharmaceutical Award 2021 | 2021 | Luxturna (voretigene neparvovec) | Novartis | Netherlands |
| Oncology Hematology | 2021 | Kymriah | Novartis | Switzerland |
| Dermatology | 2021 | Dupixent | Sanofi | Switzerland |
| Oncology Hematology | 2021 | Cablivi | Sanofi | Switzerland |
| Oncology Hematology – Best Biotechnology Product | 2021 | Oxbryta (voxelotor) tablets | Global Blood Therapeutics, Inc. (GBT) | USA |
| Cardiology – Best Digital Health Solution | 2021 | Huma Therapeutic’s Remote Patient Monitoring Platform | Huma | USA |
| Cardiology – Best Pharmaceutical Agent | 2021 | Entresto (sacubitril/valsartan) | Novartis Pharmaceuticals Corporation | USA |
| Ophthalmology – Best Medical Technology | 2021 | AcrySof IQ PanOptix Trifocal Intraocular Lens (IOL) | Alcon | USA |
